Viral Oncology

 An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumour. Oncolytic viruses are thought not only to cause direct destruction of the tumour cells, but also to stimulate host anti-tumour immune system responses.

The potential of viruses as anti-cancer agents was first realised in the early twentieth century, although coordinated research efforts did not begin until the 1960s. A number of viruses including adenovirus, reovirus, measles, herpes simplex, Newcastle disease virus, and vaccinia have been clinically tested as oncolytic agents. Most current oncolytic viruses are engineered for tumour selectivity, although there are naturally occurring examples such as reovirus and the senecavirus, resulting in clinical trials

 

  • Oncovirus
  • HPV & Other Sexually Transmitted Diseases
  • Cancer Immunotherapy

Related Conference of Viral Oncology

February 04-05, 2021

5th Annual Summit on Rare Diseases and Orphan Drugs

Bangkok, Thailand
February 25-26, 2021

4th World Congress on Pathology and Clinical Practice

Vienna, Austria
March 24-25, 2021

3rd Pathology and Infectious Disease Conference

Paris, France
April 08-09, 2021

17th Global Experts Meeting on Pathology and Laboratory Medicine

Port Moresby, New Guinea
April 12-13, 2021

18th Asia Pacific Pathology Congress

Tokyo, Japan
October 19-20, 2021

Global pathologists meet

Manila, Philippines
October 19-20, 2021

World Congress on Pathology and Microbiology

Angeles, Philippines

Viral Oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in